Laddar...
Investigation of a Thromboxane A(2) Receptor–Based Vaccine for Managing Thrombogenesis
BACKGROUND: Despite the well‐established role for the thromboxane A(2) receptor (TPR) in the development of thrombotic disorders, none of the antagonists developed to date has been approved for clinical use. To this end, we have previously shown that an antibody targeted against TPR's ligand‐bi...
Sparad:
| I publikationen: | J Am Heart Assoc |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
John Wiley and Sons Inc.
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6064912/ https://ncbi.nlm.nih.gov/pubmed/29936414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.009139 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|